| INSLX | OSMAX | INSLX / OSMAX | |
| Total Expense Ratio | 1.08 | 1.42 | 76% |
| Annual Report Gross Expense Ratio | 1.08 | 1.42 | 76% |
| Fund Existence | 7 years | 29 years | - |
| Gain YTD | 1.790 | 1.662 | 108% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.42B | 2.42B | 100% |
| Annual Yield % from dividends | 1.76 | 1.41 | 125% |
| Returns for 1 year | -11.74 | -12.11 | 97% |
| Returns for 3 years | -11.17 | -12.16 | 92% |
| Returns for 5 years | -33.25 | -34.47 | 96% |
| Returns for 10 years | N/A | -0.51 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CPXR | 33.92 | 0.98 | +2.98% |
| Uscf Daily Target 2X Copper Index ETF | |||
| SRLN | 40.40 | 0.03 | +0.07% |
| State Street® Blackstone Senior Loan ETF | |||
| NVBW | 35.60 | 0.01 | +0.04% |
| AllianzIM US Equity Buffer20 Nov ETF | |||
| RTXG | 19.24 | -0.04 | -0.19% |
| Leverage Shares 2X Long Rtx Daily ETF | |||
| LABU | 158.16 | -23.51 | -12.94% |
| Direxion Daily S&P Biotech Bull 3X ETF | |||